Recoverin as a Cancer-Associated Retinopathy Autoantigen in Lung Cancer
Author Information
Author(s): S Matsubara, Y Yamaji, M Sato, J Fujita, J Takahara
Primary Institution: Kagawa Medical School
Hypothesis
The ectopic expression of wild-type recoverin in small-cell lung cancer induces an immunological cross-reaction with the retina, leading to visual loss in cancer-associated retinopathy.
Conclusion
The study found that recoverin is expressed in a specific small-cell lung cancer cell line, supporting its role as an autoantigen in cancer-associated retinopathy.
Supporting Evidence
- Recoverin was expressed in only one SCLC cell line from a patient with cancer-associated retinopathy.
- The sequence of recoverin cDNA from the cells was identical to the human recoverin sequence.
- Previous studies indicated that autoantibodies to recoverin are highly specific for small-cell lung cancer.
Takeaway
This study shows that a protein called recoverin, which is usually found in the eye, can also be found in some lung cancer cells, and this might cause vision problems in patients.
Methodology
The expression of recoverin was examined in various human lung cancer cell lines using reverse transcription polymerase chain reaction (PCR), Northern blotting, and Western immunoblotting.
Limitations
The study only examined a limited number of lung cancer cell lines, and the findings may not be generalizable to all cases of small-cell lung cancer.
Participant Demographics
The study involved a 69-year-old male patient with small-cell lung cancer and cancer-associated retinopathy.
Want to read the original?
Access the complete publication on the publisher's website